Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
After a story on CVS, the first close moved a median −12.53%. Up 0 of 3; over the next three trading days, a median +6.62%.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$104.0B
EV / True FCF23.0x
Revenue$402.1B +7.8%
True FCF (ex-SBC)$7.3B +23.4%
Rule of 409.7%
ROIC2.7%
True FCF Yield7.0%
EPS, diluted$1.39 −62.0%
Modern Valuation (EOD)
Market Cap$104.0B
Enterprise Value$167.0B
EV / True FCF22.97
EV / FCF21.39
EV / Gross Profit—
EV / EBIT35.84
EV / Sales0.42
P / E (GAAP)58.85
P / FCF13.33
P / Oper. CF9.78
P / Book1.38
Owner & Cash Yields
True FCF Yield7.0%
FCF Yield7.5%
Owner Earn. Yield2.9%
Earnings Yield1.7%
Shareholder Yield+2.8%
Buyback Yield0.0%
Dividend Yield3.29%
Dividend / sh$2.66
Payout Ratio192%
FCF / sh$6.10
EPS (diluted)$1.39
Compounder & Returns
Rule of 409.7%
ROIC2.7%
Cash ROIC (CROIC)5.6%
GP / Assets—
ROE2.3%
ROA0.7%
Gross Margin—
Oper. Margin1.2%
Net Margin0.4%
FCF Margin1.9%
True FCF Margin1.8%
Quality & Dilution
Cash Conversion442%
Accrual Ratio−3.5%
SBC % of FCF6.9%
SBC % of Rev0.1%
Reinvest. Rate27%
Sales Growth Y/Y+7.8%
Sales 3Y CAGR+7.6%
EPS Growth Y/Y−62.0%
FCF Growth Y/Y+23.4%
FCF 3Y CAGR−16.6%
Share Change Y/Y+0.7%
Balance Sheet & Scale
Revenue (FY)$402.1B
Gross Profit (FY)—
Oper. Income (FY)$4.7B
GAAP Net Income$1.8B
True FCF (ex-SBC)$7.3B
Cash & Equiv$8.7B
Total Debt$71.7B
Net Cash (Debt)$-63.0B
Net Cash % MCap−60.5%
Debt / FCF (yrs)9.2y
Current Ratio0.841.28B sh
Price & Technicals (EOD)
Perf Week−9.52%
Perf Month−14.44%
Perf Quarter−14.10%
Perf Half Y−13.32%
Perf YTD+0.19%
SMA 20 Dist−7.02%$86.94
SMA 50 Dist−8.58%$88.43
SMA 100 Dist−14.24%$94.26
Window High−26.91%$110.60
Window Low+1.10%$79.96
RSI (14) · Vol36.759%v
Income Distribution & Cash Flow ConversionHow every dollar of CVS revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$292.1B
$322.5B
$357.8B
$372.8B
$402.1B
+7.8%
+8.3%
Cost of Revenue (COGS)
$175.8B
$196.9B
$217.1B
$206.3B
$221.2B
+7.2%
+5.9%
Operating Income (EBIT) ▸
$13.3B
$8.0B
$13.7B
$8.5B
$4.7B
−45.3%
−23.1%
Interest Expense
$2.5B
$2.3B
$2.7B
$3.0B
$3.1B
+5.4%
+5.7%
Income Tax Expense
$2.5B
$1.5B
$2.8B
$1.6B
$408.0M
−73.9%
−36.7%
GAAP Net Income ▸
$8.0B
$4.3B
$8.3B
$4.6B
$1.8B
−61.7%
−31.4%
Diluted EPS ▸
$6.02
$3.26
$6.47
$3.66
$1.39
−62.0%
−30.7%
Diluted Shares
1.33B
1.32B
1.29B
1.26B
1.27B
+0.7%
−1.1%
Balance Sheet
Cash & Equivalents
$12.7B
$13.3B
$8.5B
$8.9B
$8.7B
−1.9%
−9.0%
Inventory
$17.8B
$19.1B
$18.0B
$18.1B
$19.2B
+6.3%
+2.0%
Total Current Assets
$60.0B
$65.6B
$67.9B
$68.6B
$74.7B
+8.8%
+5.6%
Total Assets
$233.1B
$228.3B
$249.7B
$253.2B
$253.5B
+0.1%
+2.1%
Total Current Liabilities
$67.7B
$69.4B
$79.2B
$84.6B
$88.7B
+4.8%
+7.0%
Total Debt (Short + Long Term)
$71.7B
$71.7B
$71.7B
$71.7B
$71.7B
+0.0%
+0.0%
Total Liabilities
$158.2B
$156.5B
$173.1B
$177.5B
$178.2B
+0.4%
+3.0%
Stockholders' Equity
$74.8B
$71.8B
$76.6B
$75.7B
$75.4B
−0.5%
+0.2%
Net Cash / (Net Debt)
$-59.0B
$-58.4B
$-63.1B
$-62.8B
$-63.0B
−0.3%
—
Invested Capital
$133.8B
$130.1B
$139.8B
$138.5B
$138.3B
−0.1%
+0.8%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$18.3B
$16.2B
$13.4B
$9.1B
$10.6B
+16.8%
−12.6%
Depreciation & Amortization (D&A)
$4.5B
$4.2B
$4.4B
$4.6B
$4.6B
+0.2%
+0.7%
Stock-Based Compensation (SBC)
$484.0M
$447.0M
$588.0M
$540.0M
$535.0M
−0.9%
+2.5%
Capital Expenditures (CapEx)
$2.5B
$2.7B
$3.0B
$2.8B
$2.8B
+1.8%
+3.0%
Free Cash Flow (FCF) ▸
$15.7B
$13.4B
$10.4B
$6.3B
$7.8B
+23.4%
−16.1%
True FCF (ex-SBC Owner Cash)
$15.3B
$13.0B
$9.8B
$5.8B
$7.3B
+25.7%
−16.9%
Share Repurchases (Buybacks)
$0
$3.5B
$2.0B
$3.0B
$0
−100.0%
—
Dividends Paid
$2.6B
$2.9B
$3.1B
$3.4B
$3.4B
+0.7%
+6.7%
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
13 big days in a year, and what we hold on each
A big day is a close more than 3.51% from the one before, three times CVS’s median day (1.17%). On 2 of the 13, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±3.51%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayCVSWhat we hold that dayGroup (median of 3) · each
1 Jan 27, 2026−14.15%
Before our storiesgroup −3.1%, did not move with it
1Jan 27, 2026−14.15%
Before our stories
−3.1% did not move with itRDGT −6.6 · GRDN −3.1 · PETS −0.9
2 Feb 24, 2026−3.66%
Before our storiesgroup −1.9%, moved with CVS
2Feb 24, 2026−3.66%
Before our stories
−1.9% moved with CVSPETS −2.4 · RDGT −1.9 · GRDN −1.8
3 Apr 7, 2026+6.74%
Before our storiesgroup +2.1%, did not move with it
3Apr 7, 2026+6.74%
Before our stories
+2.1% did not move with itRDGT +47.5 · GRDN +2.1 · PETS −1.3
4 Apr 29, 2026+3.61%
Before our storiesgroup −0.1%, did not move with it
4Apr 29, 2026+3.61%
Before our stories
−0.1% did not move with itPETS +0.4 · GRDN −0.1 · RDGT −16.5
5 May 6, 2026+7.65%
Resultsgroup −1.8%, did not move with it
5May 6, 2026+7.65%
ResultsFirst close after the May 6 results filing
−1.8% did not move with itRDGT +17.4 · GRDN −1.8 · PETS −2.5
6 May 8, 2026+3.65%
Before our storiesgroup −0.5%, did not move with it
6May 8, 2026+3.65%
Before our stories
−0.5% did not move with itRDGT +6.1 · GRDN −0.5 · PETS −0.9
7 Jun 4, 2026+3.78%
Before our storiesgroup +2.3%, moved with CVS
7Jun 4, 2026+3.78%
Before our stories
+2.3% moved with CVSGRDN +4.2 · PETS +2.3 · RDGT −7.8
8 Aug 5, 2026−5.08%
Resultsgroup −0.8%, did not move with it
8Aug 5, 2026−5.08%
ResultsFirst close after the Aug 5 results filing
−0.8% did not move with itRDGT −1.6 · PETS −0.8 · GRDN −0.1
9 Sep 1, 2026+3.93%
Nothing on CVSgroup −0.3%, did not move with it
9Sep 1, 2026+3.93%
Nothing on CVSNo CVS story, brief or results filing in our record that day
−0.3% did not move with itGRDN +4.8 · RDGT −0.3 · PETS −3.2
10 Sep 25, 2026+4.80%
Nothing on CVSgroup −1.6%, did not move with it
10Sep 25, 2026+4.80%
Nothing on CVSNo CVS story, brief or results filing in our record that day
−1.6% did not move with itGRDN −1.4 · PETS −1.6 · RDGT −8.3
+3.0% did not move with itRDGT −1.7 · GRDN +3.0 · PETS +3.3
12 Nov 10, 2026+4.41%
Nothing on CVSgroup −1.8%, did not move with it
12Nov 10, 2026+4.41%
Nothing on CVSNo CVS story, brief or results filing in our record that day
−1.8% did not move with itGRDN +6.0 · RDGT −1.8 · PETS −3.2
13 Nov 18, 2026−5.20%
Nothing on CVSgroup 0.0%, did not move with it
13Nov 18, 2026−5.20%
Nothing on CVSNo CVS story, brief or results filing in our record that day
0.0% did not move with itGRDN −3.0 · RDGT 0.0 · PETS +0.2
A story on the same day is not a cause, and a group move is not proof either. Group: the median of GRDN, RDGT and PETS that day, the largest companies in CVS’s SEC industry; “moved with CVS” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). CVS reports before the open, so day 1 is that day’s close. 3 of 4 times, day 6 ended on the same side as day 1.
Reported Feb 10, 2026
day 1−0.09%day 6+2.61%
Reported May 6, 2026
day 1+7.65%day 6+21.59%
Reported Aug 5, 2026
day 1−5.08%day 6−9.29%
Reported Nov 4, 2026
day 1−12.53%day 6−2.07%
Next report: expected early FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 4 report: −12.44%. Four reports is a small sample.
Each line is CVS’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
CVS against three same-industry peers, a year at 100
CVS is up 2.6% in a year. Guardian Pharmacy Services is up 64.6%. Of these three, Petmed Express (−42.6%) and Ridgetech (−76.4%) did less. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The three peers are the largest US-listed companies by market value in CVS’s SEC industry (Retail-Drug Stores And Proprietary Stores) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.